```html

X Chromosome Microdeletion Syndrome

Overview

X chromosome microdeletion syndrome (XCMD) refers to a group of rare genetic conditions caused by the loss (deletion) of a small segment of DNA on the X chromosome. The size of the deleted segment can range from a few kilobases to several megabases and can involve one or more genes that are crucial for normal development.

• Who it affects: Because the X chromosome is present in two copies in females (XX) and one copy in males (XY), the clinical presentation differs by sex. Males, who have only one X chromosome, often exhibit more severe symptoms, while females may be carriers with milder or no apparent signs due to X‑inactivation.
• Prevalence: Exact prevalence is difficult to determine because many cases are identified only after targeted genetic testing. Current estimates suggest 1 in 20,000–30,000 live births for the most common X‑linked microdeletions (e.g., STS deletion causing X‑linked ichthyosis) <sup>1</sup>. Newer high‑resolution microarray platforms are increasing detection rates.

Symptoms

Because the deleted region can include different genes, symptom patterns are heterogeneous. Below is a consolidated list of the most frequently reported features, grouped by system.

General / Developmental

• Intellectual disability: ranging from mild learning difficulties to moderate–severe cognitive impairment.
• Developmental delay: delayed milestones such as sitting, walking, or speech.
• Growth abnormalities: short stature, failure to thrive, or, conversely, overgrowth in some deletions.

Neurological

• Seizures (often focal or generalized).
• Hypotonia (low muscle tone) in infancy.
• Autistic spectrum behaviors or attention‑deficit/hyperactivity disorder (ADHD).

Facial / Craniofacial

• Distinctive facial features – e.g., hypertelorism (wide‑set eyes), flattened nasal bridge, or a high‑arched palate.
• Epicanthal folds.
• Micrognathia (small jaw) in certain deletions.

Skin & Hair

• Ichthyosis (dry, scaly skin) – classic in STS deletions.
• Sparse or curly hair, especially on the scalp or eyebrows.

Ear, Nose & Throat

• Sensorineural hearing loss.
• Recurrent otitis media (middle‑ear infections).
• Choanal atresia or other nasal airway anomalies in some microdeletions.

Cardiovascular

• Congenital heart defects such as ventricular septal defect (VSD) or patent ductus arteriosus (PDA).
• Cardiomyopathy reported in rare larger deletions.

Genitourinary

• Hypospadias, cryptorchidism, or ambiguous genitalia in males.
• Recurrent urinary tract infections in females.

Endocrine & Metabolic

• Hypothyroidism (particularly with deletions affecting the POF1B gene).
• Impaired glucose tolerance in a minority of cases.

Causes and Risk Factors

XCMD is caused by a **de novo** (new) or inherited deletion of DNA on the X chromosome. The underlying mechanisms include:

• Non‑allelic homologous recombination (NAHR): misalignment of repetitive DNA sequences during meiosis, leading to loss of the intervening segment.
• Chromosomal breakage and faulty repair: exposure to ionizing radiation or certain chemicals can increase breakage risk, though most deletions occur spontaneously.
• Parent‑of‑origin effect: In females, the X chromosome carrying the deletion may be the active (non‑inactivated) X, leading to overt symptoms.

Who Is at Risk?

• Family history: If a mother is a carrier of an X‑linked microdeletion, each son has a 50 % chance of being affected, and each daughter a 50 % chance of being a carrier.
• Advanced parental age: Slightly higher rates of de novo deletions have been observed with paternal age >40 years, though data are limited.
• Previous child with XCMD: In families with one affected child, recurrence risk can be as high as 50 % for males if the mother carries the deletion.

Diagnosis

Because the clinical picture can overlap with many other genetic disorders, a high index of suspicion and confirmatory genetic testing are essential.

Clinical Evaluation

• Comprehensive medical history, including family pedigree.
• Physical examination focusing on dysmorphic features, skin, growth parameters, and neuro‑developmental status.

Laboratory & Genetic Tests

• Chromosomal microarray analysis (CMA): First‑line test; detects copy‑number variations as small as 50 kb.
• Fluorescence in‑situ hybridization (FISH): Targets specific known deletions (e.g., STS).
• Whole‑exome or whole‑genome sequencing (WES/WGS): Useful when CMA is negative but suspicion remains high.
• Targeted gene panels: Panels for X‑linked intellectual disability or ichthyosis incorporate the most common genes.

Ancillary Studies

• Neuroimaging (MRI) for structural brain anomalies.
• Audiology assessment for hearing loss.
• Cardiac echocardiogram to rule out congenital defects.
• Endocrine labs (TSH, free T4, cortisol) when clinical suspicion exists.

Treatment Options

There is no cure that restores the missing DNA; management is symptom‑driven and multidisciplinary.

Medical Therapies

• Seizure control: Antiepileptic drugs (e.g., levetiracetam, valproic acid) tailored to seizure type.
• Skin care for ichthyosis: Daily moisturizers, keratolytic agents (e.g., urea 10 % cream), and intermittent oral retinoids for severe cases.
• Hormone replacement: Levothyroxine for hypothyroidism; testosterone supplementation when hypogonadism is present.
• Behavioral medications: Stimulants for ADHD, selective serotonin reuptake inhibitors (SSRIs) for anxiety or mood disorders.

Procedural Interventions

• Ear tube placement (tympanostomy) for chronic otitis media.
• Surgical correction of congenital heart defects when indicated.
• Orthopedic interventions for scoliosis or joint contractures.
• Urological procedures for hypospadias or obstructive urinary anomalies.

Therapies & Lifestyle Modifications

• Early intervention programs: Speech, occupational, and physical therapy to maximize developmental potential.
• Structured educational plans (IEPs) and low‑dose stimulant medication when ADHD is present.
• Regular dermatologic care and sun protection for ichthyosis‑related skin fragility.
• Nutrition counseling to support growth and prevent obesity.

Living with X Chromosome Microdeletion Syndrome

Daily management focuses on maintaining health, fostering independence, and supporting the family.

• Establish a care team: Geneticist, pediatrician or internist, neurologist, dermatologist, audiologist, cardiologist, and developmental therapist.
• Routine monitoring: Schedule yearly physicals, growth charts, hearing tests, and developmental assessments.
• Medication adherence: Use pill organizers or digital reminders; review side‑effects with the prescribing physician.
• Skincare regimen: Apply emollients within minutes of bathing; avoid hot water and harsh soaps.
• Educational support: Obtain a copy of the IEP and ensure teachers understand any sensory sensitivities.
• Psychosocial support: Connect with patient‑advocacy groups such as the X‑Chromosome Disorder Alliance for peer mentorship.
• Emergency plan: Keep a written summary of the genetic diagnosis, current medications, and seizure action plan on hand.

Prevention

Because XCMD is a genetic condition, primary prevention (preventing occurrence) is limited. However, families can take steps to reduce risk of an affected pregnancy:

• Genetic counseling: Recommended for couples with a known carrier, a family history of X‑linked disorders, or previous child with XCMD.
• Prenatal testing: Chorionic villus sampling (CVS) or amniocentesis with microarray can detect deletions early in pregnancy.
• Pre‑implantation genetic diagnosis (PGD): For couples undergoing in‑vitro fertilization, embryos can be screened for the specific deletion.
• Avoidance of known teratogens: While not directly linked to XCMD, limiting maternal exposure to ionizing radiation and certain chemotherapeutic agents reduces overall chromosomal damage risk.

Complications

If left untreated or inadequately managed, XCMD can lead to several serious complications:

• Refractory seizures → risk of status epilepticus, injury, or cognitive decline.
• Severe ichthyosis → skin fissures, secondary bacterial infections, and impaired thermoregulation.
• Untreated congenital heart disease → heart failure or pulmonary hypertension.
• Progressive hearing loss → language delay and academic challenges.
• Psychiatric comorbidities (e.g., severe anxiety, major depression) → increased suicide risk.
• Renal or urinary tract obstruction → recurrent infections and possible renal insufficiency.

When to Seek Emergency Care

---

1. Mayo Clinic. “X‑linked ichthyosis.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/x-linked-ichthyosis

2. National Institutes of Health – Genetics Home Reference. “Microdeletion syndromes.” Accessed 2024. https://ghr.nlm.nih.gov/condition/microdeletion-syndrome

3. WHO. “Rare diseases: WHO guidance for health policy and planning.” 2022.

4. Cleveland Clinic. “Seizure disorders: Diagnosis and treatment.” 2023.

```